Shares of Castlight Health, inc. (NYSE:CSLT) have earned a consensus recommendation of “Hold” from the eleven analysts that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $4.54.

A number of analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Castlight Health, inc. from a “sell” rating to a “hold” rating in a report on Tuesday, June 27th. ValuEngine lowered shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Friday, May 19th. Chardan Capital assumed coverage on shares of Castlight Health, inc. in a report on Tuesday, June 6th. They set a “buy” rating and a $4.50 target price for the company. BidaskClub upgraded shares of Castlight Health, inc. from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, Dougherty & Co assumed coverage on shares of Castlight Health, inc. in a report on Wednesday, May 10th. They set a “buy” rating and a $5.50 target price for the company.

Castlight Health, inc. (CSLT) opened at 4.30 on Monday. The stock has a 50 day moving average price of $4.22 and a 200 day moving average price of $3.76. The company’s market capitalization is $561.31 million. Castlight Health, inc. has a 52-week low of $3.05 and a 52-week high of $5.50.

Castlight Health, inc. (NYSE:CSLT) last posted its quarterly earnings results on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.02. The business had revenue of $32.10 million during the quarter, compared to analyst estimates of $31.14 million. Castlight Health, inc. had a negative net margin of 42.54% and a negative return on equity of 44.33%. The company’s revenue was up 36.0% on a year-over-year basis. During the same period in the prior year, the business posted ($0.11) earnings per share. Equities research analysts forecast that Castlight Health, inc. will post ($0.25) earnings per share for the current year.

WARNING: “Castlight Health, inc. (CSLT) Given Average Rating of “Hold” by Analysts” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/08/brokerages-set-castlight-health-inc-cslt-target-price-at-4-46-updated-updated-updated.html.

In other Castlight Health, inc. news, CAO Priya Jain sold 7,858 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $3.65, for a total transaction of $28,681.70. Following the completion of the transaction, the chief accounting officer now owns 20,000 shares of the company’s stock, valued at $73,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Giovanni M. Colella sold 11,456 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $3.75, for a total transaction of $42,960.00. Following the transaction, the insider now directly owns 88,094 shares of the company’s stock, valued at approximately $330,352.50. The disclosure for this sale can be found here. Insiders sold 37,051 shares of company stock valued at $140,343 over the last 90 days. 24.38% of the stock is currently owned by company insiders.

Institutional investors have recently made changes to their positions in the stock. General Electric Co. acquired a new position in shares of Castlight Health, inc. during the second quarter worth $4,338,000. GMT Capital Corp acquired a new position in shares of Castlight Health, inc. during the first quarter worth $2,568,000. Granite Investment Partners LLC acquired a new position in shares of Castlight Health, inc. during the second quarter worth $1,613,000. Royce & Associates LP increased its position in shares of Castlight Health, inc. by 244.7% in the first quarter. Royce & Associates LP now owns 463,709 shares of the software maker’s stock worth $1,693,000 after buying an additional 329,188 shares in the last quarter. Finally, FMR LLC increased its position in shares of Castlight Health, inc. by 3.4% in the first quarter. FMR LLC now owns 7,665,919 shares of the software maker’s stock worth $27,980,000 after buying an additional 254,804 shares in the last quarter. 39.10% of the stock is owned by institutional investors and hedge funds.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Stock Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related stocks with our FREE daily email newsletter.